Credit Suisse’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.44M | Hold |
33,365
| – | – | ﹤0.01% | 1719 |
|
|
2023
Q4 | $2.38M | Buy |
33,365
+852
| +3% | +$60.9K | ﹤0.01% | 1776 |
|
|
2023
Q3 | $1.95M | Buy |
32,513
+1,936
| +6% | +$116K | ﹤0.01% | 1851 |
|
|
2023
Q2 | $2.2M | Buy |
30,577
+5,766
| +23% | +$416K | ﹤0.01% | 1829 |
|
|
2023
Q1 | $1.83M | Buy |
24,811
+1,310
| +6% | +$96.4K | ﹤0.01% | 1923 |
|
|
2022
Q4 | $1.57M | Sell |
23,501
-11,957
| -34% | -$799K | ﹤0.01% | 2008 |
|
|
2022
Q3 | $1.91M | Sell |
35,458
-100
| -0.3% | -$5.37K | ﹤0.01% | 1872 |
|
|
2022
Q2 | $1.98M | Sell |
35,558
-1,943
| -5% | -$108K | ﹤0.01% | 1912 |
|
|
2022
Q1 | $2.63M | Buy |
37,501
+978
| +3% | +$68.6K | ﹤0.01% | 1883 |
|
|
2021
Q4 | $3.52M | Sell |
36,523
-3,781
| -9% | -$364K | ﹤0.01% | 1748 |
|
|
2021
Q3 | $3.5M | Buy |
40,304
+1,204
| +3% | +$105K | ﹤0.01% | 1752 |
|
|
2021
Q2 | $3.2M | Sell |
39,100
-3,585
| -8% | -$293K | ﹤0.01% | 1854 |
|
|
2021
Q1 | $4.06M | Sell |
42,685
-38,079
| -47% | -$3.62M | ﹤0.01% | 1677 |
|
|
2020
Q4 | $5.01M | Buy |
80,764
+15,051
| +23% | +$934K | ﹤0.01% | 1520 |
|
|
2020
Q3 | $3.91M | Sell |
65,713
-10,773
| -14% | -$641K | ﹤0.01% | 1423 |
|
|
2020
Q2 | $5.34M | Sell |
76,486
-36,394
| -32% | -$2.54M | ﹤0.01% | 1269 |
|
|
2020
Q1 | $5.12M | Buy |
112,880
+34,602
| +44% | +$1.57M | ﹤0.01% | 1176 |
|
|
2019
Q4 | $5.09M | Buy |
78,278
+34,003
| +77% | +$2.21M | ﹤0.01% | 1405 |
|
|
2019
Q3 | $2.75M | Sell |
44,275
-28,729
| -39% | -$1.78M | ﹤0.01% | 1731 |
|
|
2019
Q2 | $5.2M | Buy |
73,004
+16,428
| +29% | +$1.17M | ﹤0.01% | 1318 |
|
|
2019
Q1 | $4.44M | Sell |
56,576
-7,049
| -11% | -$553K | ﹤0.01% | 1406 |
|
|
2018
Q4 | $5.39M | Buy |
63,625
+7,922
| +14% | +$671K | 0.01% | 1214 |
|
|
2018
Q3 | $9.54M | Sell |
55,703
-5,344
| -9% | -$915K | 0.01% | 1055 |
|
|
2018
Q2 | $7.89M | Buy |
61,047
+2,698
| +5% | +$349K | 0.01% | 1150 |
|
|
2018
Q1 | $6.01M | Sell |
58,349
-1,395
| -2% | -$144K | 0.01% | 1325 |
|
|
2017
Q4 | $5.1M | Sell |
59,744
-15,450
| -21% | -$1.32M | ﹤0.01% | 1446 |
|
|
2017
Q3 | $6.39M | Sell |
75,194
-97,465
| -56% | -$8.28M | 0.01% | 1290 |
|
|
2017
Q2 | $13.1M | Sell |
172,659
-30,970
| -15% | -$2.35M | 0.01% | 873 |
|
|
2017
Q1 | $13.4M | Buy |
203,629
+51,958
| +34% | +$3.43M | 0.01% | 899 |
|
|
2016
Q4 | $9.61M | Buy |
151,671
+31,557
| +26% | +$2M | 0.01% | 1046 |
|
|
2016
Q3 | $7.65M | Sell |
120,114
-16,147
| -12% | -$1.03M | 0.01% | 1180 |
|
|
2016
Q2 | $10.1M | Sell |
136,261
-16,364
| -11% | -$1.22M | 0.01% | 1024 |
|
|
2016
Q1 | $10.2M | Buy |
152,625
+17,468
| +13% | +$1.17M | 0.01% | 1004 |
|
|
2015
Q4 | $9.14M | Sell |
135,157
-40,638
| -23% | -$2.75M | 0.01% | 1110 |
|
|
2015
Q3 | $9.39M | Sell |
175,795
-41,472
| -19% | -$2.22M | 0.01% | 1079 |
|
|
2015
Q2 | $13.7M | Buy |
217,267
+69,874
| +47% | +$4.4M | 0.01% | 958 |
|
|
2015
Q1 | $7.09M | Buy |
147,393
+6,023
| +4% | +$290K | 0.01% | 1277 |
|
|
2014
Q4 | $4.69M | Sell |
141,370
-6,048
| -4% | -$201K | ﹤0.01% | 1563 |
|
|
2014
Q3 | $4.32M | Sell |
147,418
-53,690
| -27% | -$1.57M | ﹤0.01% | 1599 |
|
|
2014
Q2 | $7.82M | Buy |
201,108
+40,875
| +26% | +$1.59M | 0.01% | 1347 |
|
|
2014
Q1 | $6.72M | Sell |
160,233
-8,401
| -5% | -$353K | 0.01% | 1329 |
|
|
2013
Q4 | $5.53M | Buy |
168,634
+79,627
| +89% | +$2.61M | 0.01% | 1493 |
|
|
2013
Q3 | $2.4M | Buy |
89,007
+33,428
| +60% | +$902K | ﹤0.01% | 1911 |
|
|
2013
Q2 | $1.3M | Buy |
+55,579
| New | +$1.3M | ﹤0.01% | 2253 |
|